16.92USD-1.34%Mkt Cap: 5.40B $P/E: 45.73Today
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, I…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Pricier
1M Perf
Lower
Indicators:|
Key Statistics
Company
Market Cap5.40B $
Enterprise Value8.10B $
Revenue (TTM)3.05B $
Gross Profit1.11B $
Net Income (TTM)72.06M $
Revenue/Share9.681 USD
Last Price16.92 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8.7K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS03168L1052
Valuation
P/E (Trailing)45.73
P/E (Forward)15.41
PEG—
EV/EBITDA12.13
EV/Revenue2.66
P/S1.81
P/B-121.90
EPS (TTM)0.37
EPS (Forward)1.12
52W Range
7.66591% of range17.86
52W High17.86 USD
52W Low7.665 USD
Profitability
Gross Margin36.88%
Oper. Margin19.57%
EBITDA Margin21.92%
Profit Margin2.39%
ROE-101.78%
ROA1.96%
Growth
Revenue Growth3.90%
Earnings Growth384.60%
Cash Flow & Leverage
Operating CF339.99M $
CapEx (TTM)114.36M $
FCF Margin3.33%
FCF Yield1.88%
Net Debt2.50B $
Net Debt/EBITDA3.74
Balance Sheet
Debt/Equity-37.98
Current Ratio2.47
Quick Ratio1.51
Book Value/Sh-0.1420 USD
Cash/Share0.6290 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)17.25 USD
Upside (mean)+2.0%
Target Range16.00 USD – 19.00 USD
$16.00+2.0% to mean$19.00
# Analysts4
Ownership
Shares Out.319.33M
Float178.41M
Insiders44.12%
Institutions52.18%
Short Interest
Short Ratio4.3d
Short % Float3.82%
Short % Out.2.48%
Shares Short7.92M
Short (prev mo.)7.96M
Technical
SMA 5013.85 (+22.2%)
SMA 20012.61 (+34.2%)
Beta1.32
S&P 52W Chg20.05%
Avg Vol (30d)1.76M
Avg Vol (10d)2.75M
Technical Indicators
RSI (14)74.8
MACD1.0310
MACD Signal0.9923
MACD Hist.+0.0388
BB Upper18.69 USD
BB Middle15.87 USD
BB Lower13.05 USD
BB Width35.53%
ATR (14)0.5495 USD
Vol Ratio (20d)0.66x